News

Biosenta Inc. has signed an MOU with Voran Group Ventures Ltd. for the commercialization of Biosenta’s Tri-Filler® antimicrobial products.

How to mix the right ingredients for an environmentally friendly disinfectant

University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry

Biosenta announces that it has granted to certain directors, officers, employees and consultants of the Company 350,000 stock options.

Biosenta will enter into a series of prime plus 5% unsecured promissory notes in consideration for cash investments in the amount of $85,000

Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360.

Biosenta’s stock closed at 0.75 CAD +0.37 (97.37%). This is in step with Biosenta’s strategic business plan grow the company.

A strategic licensing partnership with Kleen Bee Labs was finalized today. This license will give the rights for distribution of DualXtiv.